Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMUNO-CHIQ: IXCHIQ Vaccine Against Chikungunya
NCT07846293Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of chikungunya vaccine (live) in Chikungunya (CHIKV). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
chikungunya vaccine (live)
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on NCT07846293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07846293.